BINAXNOW: TAKING COVID-19 TESTING TO A NEW LEVEL

BINAXNOW: TAKING COVID-19 TESTING TO A NEW LEVEL

RAPID ANTIGEN TEST AND MOBILE NAVICA APP DESIGNED TO HELP RESTORE MORE CONFIDENCE IN DAILY LIFE.

NAVICA APP SUPPORTING COVID-19 TESTING

NAVICA APP SUPPORTING COVID-19 TESTING

Purchased your BinaxNOW Home Test and now you need the integrated NAVICA app?

CLEARED FOR TAKEOFF: BINAXNOW, NAVICA AND UNITED

CLEARED FOR TAKEOFF: BINAXNOW, NAVICA AND UNITED

OUR BINAXNOW HOME TESTS AND NAVICA APP ARE MAKING RETURN TRIPS FROM INTERNATIONAL TRAVEL EASIER.

OVER-THE-COUNTER RAPID COVID-19 TESTING, IN YOUR HANDS

OVER-THE-COUNTER RAPID COVID-19 TESTING, IN YOUR HANDS

BINAXNOW AG IS NOW AVAILABLE OVER-THE-COUNTER, BRINGING ACCESSIBLE COVID-19 RAPID SELF-TESTING TO THE MASSES.

NO MORE BARRIERS. NO MORE INCONVENIENCES. ANSWERS, WHEN AND WHERE YOU NEED THEM.

 

Even while vaccines are rolling out, COVID-19 testing will remain crucial to helping us all return to normal as we begin to engage in everyday life once again. The BinaxNOW COVID-19 Self Test card is identical to the professional-use test card, used since August 2020, and is the most studied and widely available rapid antigen test and is now available as a Self Test.

 

Now, with BinaxNOW authorized for over the counter for frequent asymptomatic use, we are making testing directly available for fast results, when and where you need it. You can now access our BinaxNOW test in 3 ways: at your local retailer over the counter self-test, or proctored at-home or from your healthcare professional. This combination will help attack the pandemic on critical fronts – speed, simplicity, affordability, access and reliability.

 

No more lines, no more wait times, no more barriers and no more inconveniences. Answers are now in your hands.






THE BEST TEST FOR YOU
I am interested in COVID testing for myself or family member READ MORE
For myself or family member
Find out about our BinaxNOW™ COVID-19 Antigen Self Test and where to buy.
I am interested in COVID testing for myself with a trained telehealth professional to assist me READ MORE
For myself with a trained telehealth guide
Learn more about BinaxNOW™ Ag Card Home Test.
I am a healthcare professional interested in COVID-19 testing READ MORE
I am a healthcare professional
Learn more about the BinaxNOW™ COVID-19 Ag Card for professional use.
Tests for my K-12 schools READ MORE
Tests for my K-12 schools
Learn more about rapid COVID-19 testing at schools.
I am interested in tests for students and faculty at our colleges or universities. READ MORE
Tests for my university
Learn more about COVID-19 testing for your college and university.
I am interested in testing for business employees READ MORE
Tests for employees at my business
Learn more about workplace COVID-19 testing.
THE FUNDAMENTALS
OUR QUICK GUIDE TO RAPID COVID-19 TESTING

OUR QUICK GUIDE TO RAPID COVID-19 TESTING

Here's what to look for when choosing your rapid coronavirus test.

BINAXNOW: WHAT YOU NEED TO KNOW READ MORE
BINAXNOW: WHAT YOU NEED TO KNOW
A step-by-step video guide to conducting a BinaxNOW Self Test in the comfort of your own home.
OVER-THE-COUNTER RAPID COVID-19 TESTING, IN YOUR HANDS READ MORE
OVER-THE-COUNTER RAPID COVID-19 TESTING, IN YOUR HANDS
BinaxNOW Self Test now available over-the-counter, bringing accessible COVID-19 rapid self-testing to the masses.
NEW GUIDED, AT-HOME COVID TEST A MAJOR ADVANCEMENT READ MORE
NEW GUIDED, AT-HOME COVID TEST A MAJOR ADVANCEMENT
Our BinaxNOW Home Test can be used at home through guided online service.
USE THE NAVICA APP

 

 

 

For the professional use and at-home versions of BinaxNOW, you can receive verified tests results to your phone via our NAVICA mobile app.

 

DOWNLOAD THE APP

Get the app before your first test.

Apple Store

Google Play

GET OUT THERE!
CLEARED FOR TAKEOFF: BINAXNOW, NAVICA AND UNITED

CLEARED FOR TAKEOFF: BINAXNOW, NAVICA AND UNITED

OUR BINAXNOW HOME TESTS AND NAVICA APP ARE MAKING RETURN TRIPS FROM INTERNATIONAL TRAVEL EASIER.

BACK ON CAMPUS WITH RAPID TESTS READ MORE
BACK ON CAMPUS WITH RAPID TESTS
Reliable, rapid tests bring students on campus.
WITH BINAXNOW, COMPANIES TAKING CARE OF THEIR BUSINESS READ MORE
WITH BINAXNOW, COMPANIES TAKING CARE OF THEIR BUSINESS
How frequent rapid testing can help companies return to in-person work.
AS WE COME BACK, OUR NEW TEST CAN HELP OPEN DOORS READ MORE
AS WE COME BACK, OUR NEW TEST CAN HELP OPEN DOORS
Chris Scoggins explains key features of BinaxNOW test + NAVICA app combo.
MAKING A DIFFERENCE
FASTER ISOLATION, REDUCE SPREAD THE ROLE OF BINAXNOW IN COMMUNITY TESTING

FASTER ISOLATION, REDUCE SPREAD THE ROLE OF BINAXNOW IN COMMUNITY TESTING

AFFORDABILITY, RELIABILITY, ACCESSIBILITY: THE IMPACT OF BINAXNOW IN COMMUNITIES.

WITH BINAXNOW RAPID COVID-19 TEST, STUDENTS, STAFF ARE BACK IN SCHOOLS READ MORE
WITH BINAXNOW RAPID COVID-19 TEST, STUDENTS, STAFF ARE BACK IN SCHOOLS
Rapid results are enabling in-person learning while helping contain coronavirus outbreaks.
For Parents and Schools READ MORE
PARENTS, SCHOOLS: BINAXNOW OFFERS COVID-19 ANSWERS
With the prospect of kids returning to school, we’re here to help.
WE'RE UPPING THE ANTE ON COVID-19 ANTIGEN TESTING READ MORE
WE'RE UPPING THE ANTE ON COVID-19 ANTIGEN TESTING
BinaxNOW: With a swab & a card, reliable results in 15 minutes for coronavirus.
THE SCIENCE
WITH COVID VACCINES, WHY HAVE TESTING? HERE'S WHY.

WITH COVID VACCINES, WHY HAVE TESTING? HERE'S WHY.

AS DAILY LIFE OPENS UP, CORONAVIRUS IS THE GUEST THAT WILL CONTINUE TO OVERSTAY ITS WELCOME. THAT'S WHY WE TEST.

HOW WE TRACK COVID-19 VARIANTS TO HELP CONTAIN THE PANDEMIC READ MORE
HOW WE TRACK COVID-19 VARIANTS TO HELP CONTAIN THE PANDEMIC
Our scientists use next-generation sequencing to analyze and detect COVID-19 variants.
RAPID COVID TESTS: MORE IMPORTANT THAN EVER READ MORE
RAPID COVID TESTS: MORE IMPORTANT THAN EVER
With much of the world calculating when "normal" will return, rapid tests will help us get and stay there.
DON'T EXHALE YET: COVID-19 ISN'T DONE TESTING US READ MORE
DON'T EXHALE YET: COVID-19 ISN'T DONE TESTING US
As the vaccine rollout continues, the necessity of preventative measures remains, including testing.
VIDEO: ATTACKING THIS VIRUS FROM EVERY ANGLE WE CAN PLAY VIDEO
VIDEO: ATTACKING THIS VIRUS FROM EVERY ANGLE WE CAN
BinaxNOW and NAVICA are strong tools to help us get back to daily life.
VIDEO: BINAXNOW CAN HELP  LOWER RISK OF DISEASE SPREAD
VIDEO: BINAXNOW CAN HELP LOWER RISK OF DISEASE SPREAD
Explaining the trade-offs between rapid antigen tests vs. lab-based tests.
VIDEO: KEY TO COVID-19 TEST IS COMMUNICATION OF RESULTS PLAY VIDEO
VIDEO: KEY TO COVID-19 TEST IS COMMUNICATION OF RESULTS
Expert says a test with an app improves efficiency of communicating results.
OUR MISSION
ILLNESS CAN STEAL LIFE'S PRECIOUS MOMENTS READ MORE
ILLNESS CAN STEAL LIFE'S PRECIOUS MOMENTS
Our life-changing technology helps get them back.
A SUSTAINABLE FUTURE STARTS WITH HEALTH READ MORE
A SUSTAINABLE FUTURE STARTS WITH HEALTH
We're designing access and affordability into our products to reach one in three people every year by 2030.
OUR CONTRIBUTIONS TO THE COVID-19 RESPONSE READ MORE
OUR CONTRIBUTIONS TO THE COVID-19 RESPONSE
We're developing technologies, expanding access and sharing resources as part of our efforts to limit the coronavirus.
RAPID RESULTS, WHEN AND WHERE YOU NEED THEM

RAPID RESULTS, WHEN
AND WHERE YOU NEED THEM

Affordable and accessible rapid testing options are empowering people with the information they need for their health.


Connect with Us

The BinaxNOW™ COVID-19 Antigen Self Test is a lateral flow immunoassay intended for the qualitative detection of nucleocapsid protein antigen from SARS-CoV-2 from individuals with or without symptoms or other epidemiological reasons to suspect COVID-19 infection when tested twice over three days with at least 36 hours between tests. This test is authorized for non-prescription home use with self-collected direct anterior nasal (nares) swab samples from individuals aged 15 years or older or adult collected anterior nasal swab samples from individuals aged two years or older.

 

The BinaxNOW COVID-19 Ag 2 Card is a lateral flow immunoassay intended for the qualitative detection of nucleocapsid protein antigen from SARS-CoV-2 in direct anterior nasal (nares) swab samples from COVID-19 symptomatic individuals tested twice over three days with at least 36 hours between tests within the first seven days of symptom onset.

 

This test is authorized for use with direct anterior nasal (nares) swab samples from individuals without symptoms or other epidemiological reasons to suspect COVID-19, when tested twice over three days with at least 36 hours between tests. Testing is limited to laboratories certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA), 42 U.S.C. §263a, that meet the requirements to perform moderate, high, or waived complexity tests. This test is authorized for use at the Point of Care (POC), i.e., in patient care settings operating under a CLIA Certificate of Waiver, Certificate of Compliance, or Certificate of Accreditation.

 

The BinaxNOW COVID-19 Ag Card 2 Home Test is a lateral flow immunoassay intended for the qualitative detection of nucleocapsid protein antigen from SARS-CoV-2 in direct anterior nasal (nares) swabs from individuals with or without symptoms or other epidemiological reasons to suspect COVID-19 infection when tested twice over three days with at least 36 hours between tests. This test is authorized for non-prescription home use with self-collected observed direct anterior nasal (nares) swab samples from individuals aged 15 years or older or adult collected anterior nasal swab samples from individuals aged two years or older. The BinaxNOW COVID-19 Ag Card 2 Home Test is to be performed only with the supervision of a telehealth proctor.

 

The BinaxNOW COVID-19 Ag tests have not been FDA cleared or approved. They have been authorized by the FDA under an emergency use authorization. The tests have been authorized only for the detection of proteins from SARS-CoV-2, not for any other viruses or pathogens, and are only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Federal Food, Drug and Cosmetic Act, 21 U.S.C. § 360bbb-3(b)(1), unless the declaration is terminated or authorization is revoked sooner.

FOR THE LATEST ON LIFE-CHANGING TECHNOLOGY, GET ABBOTT EDGE DELIVERED TO YOUR INBOX

Please Enter Your Email

*Required 

Intended for U.S. residents only. Please review our privacy policy and terms & conditions.

Abbott EDGE Archive: We've brought our past issues together here, with new installments added each month. Thanks for reading.

true
accessibility

You are about to exit for another Abbott country or region specific website

Please be aware that the website you have requested is intended for the residents of a particular country or region, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions.


The website you have requested also may not be optimized for your specific screen size.

Do you wish to continue and exit this website?

accessibility

You are about to exit the Abbott family of websites for a 3rd party website

Links which take you out of Abbott worldwide websites are not under the control of Abbott, and Abbott is not responsible for the contents of any such site or any further links from such site. Abbott is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement of the linked site by Abbott.


The website that you have requested also may not be optimized for your screen size.

Do you wish to continue and exit this website??